Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletion

NeuroImage

Volumn 43, Issue 4, 2008, Pages 764-774

  Nugent, Allison C ^a   Neumeister, Alexander ^b   Goldman, David ^c   Herscovitch, Peter ^d   Charney, Dennis S ^e   Drevets, Wayne C ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

5 HTTLPR; FDG; Major depressive disorder; Positron emission tomography; Tryptophan depletion

Indexed keywords

AMINO ACID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; SEROTONIN TRANSPORTER; TRYPTOPHAN;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISCRIMINANT ANALYSIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE METABOLISM; HUMAN; MAJOR DEPRESSION; MALE; NEUROTRANSMISSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; REMISSION; SYMPTOMATOLOGY; VALIDATION PROCESS;

ADULT; BRAIN; DEPRESSION; DISCRIMINANT ANALYSIS; FEMALE; FLUORODEOXYGLUCOSE F18; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE; HUMANS; MALE; PHENOTYPE; PLACEBO EFFECT; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN;

EID: 54449093878     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.07.040     Document Type: Article

References (71)

1. Baumann P. Transport systems and enzymes involved in the metamorphosis of tryptophan into serotonin. Pharmacopsychiatry 18 2 (1985) 188-192
2. Blier P., and de Montigny C. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses. Biol. Psychiatry. 44 5 (1998) 313-323
3. Bremner J.D., Innis R.B., Salomon R.M., Staib L.H., Ng C.K., Miller H.L., Bronen R.A., Krystal J.H., Duncan J., Rich D., Price L.H., Malison R., Dey H., Soufer R., and Charney D.S. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch. Gen. Psychiatry. 54 4 (1997) 364-374
4. Caldecott-Hazard S., Mazziotta J., and Phelps M. Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography. J. Neurosci. 8 6 (1988) 1951-1961
5. Cannon D.M., Ichise M., Fromm S.J., Nugent A.C., Rollis D., Gandhi S.K., Klaver J.M., Charney D.S., Manji H.K., and Drevets W.C. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol. Psychiatry. 60 3 (2006) 207-217
6. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 5631 (2003) 386-389
7. Charney D.S., and Drevets W.C. The neurobiological basis of anxiety disorders. In: Davis K., Charney D.S., Coyle J., and Nemeroff C.B. (Eds). Psychopharmacology: the Fifth Generation of Progress (2002), Lippincott, Philadelphia
8. Cohen Z., Bonvento G., Lacombe P., and Hamel E. Serotonin in the regulation of brain microcirculation. Prog. Neurobiol. 50 4 (1996) 335-362
9. Collier D.A., Stober G., Li T., Heils A., Catalano M., Di Bella D., Arranz M.J., Murray R.M., Vallada H.P., Bengel D., Muller C.R., Roberts G.W., Smeraldi E., Kirov G., Sham P., and Lesch K.P. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol. Psychiatry. 1 6 (1996) 453-460
10. Coryell W., Nopoulos P., Drevets W., Wilson T., and Andreasen N.C. Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and prognostic implications. Am. J. Psychiatry. 162 9 (2005) 1706-1712
11. Costanza M.C., and Afifi A.A. Comparison of stopping rules in forward stepwise discriminant analysis. J. Am. Stat. Assoc. 74 (1979) 777-785
12. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., and Heninger G.R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiatry. 47 5 (1990) 411-418
13. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., Moreno F.A., Heninger G.R., and Charney D.S. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol. Psychiatry. 46 2 (1999) 212-220
14. Delgado P.L., Moreno F.A., Onate L., and Gelenberg A.J. Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients. Int. J. Neuropsychopharmacol. 5 1 (2002) 63-66
15. Drevets W.C. Neuroplasticity in mood disorders. Dialogues in Clinical Neuroscience 6 2 (2004) 199-216
16. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., and Raichle M.E. A functional anatomical study of unipolar depression. J. Neurosci. 12 9 (1992) 3628-3641
17. Drevets W.C., Price J.L., Simpson Jr. J.R., Todd R.D., Reich T., Vannier M., and Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 6627 (1997) 824-827
18. Drevets W.C., Bogers W., and Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur. Neuropsychopharmacol. 12 6 (2002) 527-544
19. Drevets W.C., Price J.L., Bardgett M.E., Reich T., Todd R.D., and Raichle M.E. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol. Biochem. Behav. 71 3 (2002) 431-447
20. Drevets W.C., Gadde K.M., and Krishnan K.R. In: Charney D.S. (Ed). Neuroimaging Studies of Mood Disorders. Neurobiology of Mental Illness (2004), Oxford University Press, Oxford, UK 461-490
21. Eley T.C., Sugden K., Corsico A., Gregory A.M., Sham P., McGuffin P., Plomin R., and Craig I.W. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol. Psychiatry. 9 10 (2004) 908-915
22. Grabe H.J., Lange M., Wolff B., Volzke H., Lucht M., Freyberger H.J., John U., and Cascorbi I. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol. Psychiatry. 10 2 (2005) 220-224
23. Hajos M., Richards C.D., Szekely A.D., and Sharp T. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 87 1 (1998) 95-108
24. Hariri A.R., and Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn. Sci. 10 4 (2006) 182-191
25. Hasler G., Fromm S., Carlson P.J., Luckenbaugh D.A., Waldeck T., Geraci M., Roiser J.P., Neumeister A., Meyers N., Charney D.S., and Drevets W.C. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch. Gen. Psychiatry. 65 5 (2008) 521-531
26. Henn F.A., and Vollmayr B. Stress models of depression: forming genetically vulnerable strains. Neurosci. Biobehav. Rev. 29 4-5 (2005) 799-804
27. Herman J.P., Ostrander M.M., Mueller N.K., and Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry. 29 8 (2005) 1201-1213
28. Herry C., and Garcia R. Prefrontal cortex long-term potentiation, but not long-term depression, is associated with the maintenance of extinction of learned fear in mice. J. Neurosci. 22 2 (2002) 577-583
29. Hoefgen B., Schulze T.G., Ohlraun S., von Widdern O., Hofels S., Gross M., Heidmann V., Kovalenko S., Eckermann A., Kolsch H., Metten M., Zobel A., Becker T., Nothen M.M., Propping P., Heun R., Maier W., and Rietschel M. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol. Psychiatry. 57 3 (2005) 247-251
30. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., and Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 78 5 (2006) 815-826
31. Kasper S., Tauscher J., Willeit M., Stamenkovic M., Neumeister A., Kufferle B., Barnas C., Stastny J., Praschak-Rieder N., Pezawas L., de Zwaan M., Quiner S., Pirker W., Asenbaum S., Podreka I., and Brucke T. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder-implications for psychopharmacology. World J. Biol. Psychiatry. 3 3 (2002) 133-146
32. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., and Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch. Gen. Psychiatry. 62 5 (2005) 529-535
33. Ketter T.A., Kimbrell T.A., George M.S., Dunn R.T., Speer A.M., Benson B.E., Willis M.W., Danielson A., Frye M.A., Herscovitch P., and Post R.M. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol. Psychiatry. 49 2 (2001) 97-109
34. Kim D.K., Lim S.W., Lee S., Sohn S.E., Kim S., Hahn C.G., and Carroll B.J. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11 1 (2000) 215-219
35. Kim H., Lim S.W., Kim S., Kim J.W., Chang Y.H., Carroll B.J., and Kim D.K. Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. Jama 296 13 (2006) 1609-1618
36. Kraft J.B., Peters E.J., Slager S.L., Jenkins G.D., Reinalda M.S., McGrath P.J., and Hamilton S.P. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol. Psychiatry. 61 6 (2007) 734-742
37. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 5292 (1996) 1527-1531
38. Leyton M., Ghadirian A.M., Young S.N., Palmour R.M., Blier P., Helmers K.F., and Benkelfat C. Depressive relapse following acute tryptophan depletion in patients with major depressive disorder. J. Psychopharmacol. 14 3 (2000) 284-287
39. Maddock R.J. The retrosplenial cortex and emotion: new insights from functional neuroimaging of the human brain. Trends Neurosci. 22 7 (1999) 310-316
40. Mann J.J., Huang Y.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., and Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry. 57 8 (2000) 729-738
41. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., Silva J.A., McGinnis S., Glass T.G., Martin C.C., and Fox P.T. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8 4 (1997) 1057-1061
42. McKie S., Del-Ben C., Elliott R., Williams S., Del Vai N., Anderson I., and Deakin J.F. Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl.) (2005)
43. Mendlewicz J., Massat I., Souery D., Del-Favero J., Oruc L., Nothen M.M., Blackwood D., Muir W., Battersby S., Lerer B., Segman R.H., Kaneva R., Serretti A., Lilli R., Lorenzi C., Jakovljevic M., Ivezic S., Rietschel M., Milanova V., and Van Broeckhoven C. Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study. Eur. J. Hum. Genet. 12 5 (2004) 377-382
44. Milak M.S., Parsey R.V., Keilp J., Oquendo M.A., Malone K.M., and Mann J.J. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch. Gen. Psychiatry. 62 4 (2005) 397-408
45. Moreno F.A., Gelenberg A.J., Heninger G.R., Potter R.L., McKnight K.M., Allen J., Phillips A.P., and Delgado P.L. Tryptophan depletion and depressive vulnerability. Biol. Psychiatry. 46 4 (1999) 498-505
46. Moreno F.A., Rowe D.C., Kaiser B., Chase D., Michaels T., Gelernter J., and Delgado P.L. Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol. Psychiatry. 7 2 (2002) 213-216
47. Morris J.S., Smith K.A., Cowen P.J., Friston K.J., and Dolan R.J. Covariation of activity in habenula and dorsal raphe nuclei following tryptophan depletion. Neuroimage 10 2 (1999) 163-172
48. Neumeister A., Praschak-Rieder N., Besselmann B., Rao M.L., Gluck J., and Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch. Gen. Psychiatry. 54 2 (1997) 133-138
49. Neumeister A., Konstantinidis A., Stastny J., Schwarz M.J., Vitouch O., Willeit M., Praschak-Rieder N., Zach J., de Zwaan M., Bondy B., Ackenheil M., and Kasper S. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch. Gen. Psychiatry. 59 7 (2002) 613-620
50. Neumeister A., Nugent A.C., Waldeck T., Geraci M., Schwarz M., Bonne O., Bain E.E., Luckenbaugh D.A., Herscovitch P., Charney D.S., and Drevets W.C. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch. Gen. Psychiatry. 61 8 (2004) 765-773
51. Neumeister A., Drevets W.C., Belfer I., Luckenbaugh D.A., Henry S., Bonne O., Herscovitch P., Goldman D., and Charney D.S. Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology 31 8 (2006) 1750-1756
52. Neumeister A., Hu X.Z., Luckenbaugh D.A., Schwarz M., Nugent A.C., Bonne O., Herscovitch P., Goldman D., Drevets W.C., and Charney D.S. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch. Gen. Psychiatry. 63 9 (2006) 978-986
53. Nugent A.C., Milham M.P., Bain E.E., Mah L., Cannon D.M., Marrett S., Zarate C.A., Pine D.S., Price J.L., and Drevets W.C. Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage 30 2 (2006) 485-497
54. Ongur D., and Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb. Cortex. 10 3 (2000) 206-219
55. Ongur D., Ferry A.T., and Price J.L. Architectonic subdivision of the human orbital and medial prefrontal cortex. J. Comp. Neurol. 460 3 (2003) 425-449
56. O'Reardon J.P., Chopra M.P., Bergan A., Gallop R., DeRubeis R.J., and Crits-Christoph P. Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants. Biol. Psychiatry. 55 9 (2004) 957-959
57. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., and Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 8 6 (2005) 828-834
58. Quirk G.J., and Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33 1 (2008) 56-72
59. Rausch J.L., Johnson M.E., Fei Y.J., Li J.Q., Shendarkar N., Hobby H.M., Ganapathy V., and Leibach F.H. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol. Psychiatry. 51 9 (2002) 723-732
60. Ressler K.J., and Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety 12 Suppl 1 (2000) 2-19
61. Roiser J.P., Levy J., Fromm S.J., Wang H., Hasler G., Sahakian B.J., and Drevets W.C. The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers. Neuropsychopharmacology 33 8 (2008) 1992-2006
62. Serretti A., Lilli R., Lorenzi C., Lattuada E., Cusin C., and Smeraldi E. Serotonin transporter gene (5-HTTLPR) and major psychoses. Mol. Psychiatry. 7 1 (2002) 95-99
63. Shioe K., Ichimiya T., Suhara T., Takano A., Sudo Y., Yasuno F., Hirano M., Shinohara M., Kagami M., Okubo Y., Nankai M., and Kanba S. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48 4 (2003) 184-188
64. Shumake J., Edwards E., and Gonzalez-Lima F. Opposite metabolic changes in the habenula and ventral tegmental area of a genetic model of helpless behavior. Brain Res. 963 1-2 (2003) 274-281
65. Smith D.F. Neuroimaging of serotonin uptake sites and antidepressant binding sites in the thalamus of humans and 'higher' animals. Eur. Neuropsychopharmacol. 9 6 (1999) 537-544
66. Smith K.A., Fairburn C.G., and Cowen P.J. Relapse of depression after rapid depletion of tryptophan. Lancet 349 9056 (1997) 915-919
67. Smith G.S., Lotrich F.E., Malhotra A.K., Lee A.T., Ma Y., Kramer E., Gregersen P.K., Eidelberg D., and Pollock B.G. Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology 29 12 (2004) 2226-2234
68. Spillmann M.K., Van der Does A.J., Rankin M.A., Vuolo R.D., Alpert J.E., Nierenberg A.A., Rosenbaum J.F., Hayden D., Schoenfeld D., and Fava M. Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology (Berl.) 155 2 (2001) 123-127
69. Surtees P.G., Wainwright N.W., Willis-Owen S.A., Luben R., Day N.E., and Flint I. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol. Psychiatry 59 3 (2005) 224-229
70. Vielhaber K., Riemann D., Feige B., Kuelz A., Kirschbaum C., and Voderholzer U. Impact of experimentally induced serotonin deficiency by tryptophan depletion on saliva cortisol concentrations. Pharmacopsychiatry 38 2 (2005) 87-94
71. Yu Y.W., Tsai S.J., Chen T.J., Lin C.H., and Hong C.J. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol. Psychiatry. 7 10 (2002) 1115-1119